Phase 2 Locally Advanced Rectal Cancer (LARC) Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer
Locally Advanced Rectal Cancer (LARC)
First Affiliated Hospital of Zhejiang University116 enrolled1 locationNCT06864013
Recruiting
Phase 2
A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
Locally Advanced Rectal Cancer (LARC)
First Affiliated Hospital of Wenzhou Medical University30 enrolled1 locationNCT07347951
Recruiting
Phase 2
Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.
Locally Advanced Rectal Cancer (LARC)
brenner baruch134 enrolled2 locationsNCT06940388
Recruiting
Phase 2
Optimizing Immunotherapy Combined With Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Locally Advanced Rectal Cancer (LARC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences228 enrolled2 locationsNCT07040098